Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-01-16 | Deciphera Pharmaceuticals, Inc. | Sherman Matthew L
(EVP & Chief Medical Officer) |
S | Common Stock | D | 2435 | $14.47 - $14.47 | $35,233 |
| 2024-01-16 | Deciphera Pharmaceuticals, Inc. | Pitman Jama
(SVP, Chief Development Officer) |
S | Common Stock | D | 1624 | $14.47 - $14.47 | $23,498 |
| 2023-12-13 | Deciphera Pharmaceuticals, Inc. | Sherman Matthew L
(EVP & Chief Medical Officer) |
S | Common Stock | D | 2792 | $15.37 - $15.37 | $42,904 |
| 2023-11-30 | Deciphera Pharmaceuticals, Inc. | Martin Daniel C.
(Chief Commercial Officer) |
S | Common Stock | D | 17801 | $12.57 - $12.57 | $223,755 |
| 2023-10-30 | Deciphera Pharmaceuticals, Inc. | Hoerter Steven L.
(President and CEO) |
S | Common Stock | D | 21573 | $12.02 - $12.02 | $259,255 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |